** Shares of medical diagnostics co Lantheus Holdings LNTH.O fall 20% to over 2-month low of $83.71
** Co forecast 2025 sales to be between $1.55 bln and $1.59 bln; analysts were expecting 2025 sales to be $1.59 bln - data compiled by LSEG
** Co forecast 2025 adj. EPS between $6.60 and $6.70; analysts were expecting it to be $7.08/shr
** Co posts Q1 sales of $372.8 mln, below analysts' est. of $379 mln
** Reports Q1 adj. profit of $1.53/shr, below est. of $1.66/shr
** Including session moves, stock down 7% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。